Opaleye Management Inc. Myovant Sciences Ltd. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$17.07 - $24.56 $4.26 Million - $6.14 Million	-249,800 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$20.46 - $25.18 $8.85 Million - $10.9 Million	-432,700 Reduced 63.4%	249,800 $5.14 Million
Q2 2020 Aug 14, 2020	BUY	$7.34 - $20.84 $194,510 - $552,260	26,500 Added 4.04%	682,500 $14.1 Million
Q1 2020 May 15, 2020	BUY	$6.55 - $14.76 $4.3 Million - $9.68 Million	656,000 New	656,000 $4.95 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.